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Knee arthroplastyAbstract Background and objectives: Postdural puncture headache is a relatively common compli-
cation in spinal anesthesia, so several kinds of regimens have been suggested for treatment of this
problem. The aim of this study was to evaluate the efﬁcacy and safety of prophylactic administra-
tion of intravenous caffeine sodium benzoate for prevention of postdural puncture headache
(PDPH) in young adult patients received spinal anesthesia.
Methods: One hundred ASA I and II patients undergoing elective knee surgeries either arthroscopy
or anterior cruciate ligament reconstruction (ACL reconstruction) were included in this study.
Patients were randomized by double-blind, placebo-controlled design to receive intravenously
(IV) either 10 mL normal saline as control group (group S) or 10 ml with 500 mg caffeine sodium
benzoate (CSB) as caffeine group (group C) during the ﬁrst 60 min after spinal anesthesia
administration. The patient’s electrocardiogram, noninvasive blood pressure, and pulse oximetry
were monitored and recorded. The patients’ headaches were evaluated by using the visual analog
182 A. Ragab, K.N. Facharztscale (VAS), and the severity of the headache was classiﬁed as follows: no headache = 0, mild head-
ache 63, moderate headache from 4 to 6 and severe headache P7. Analgesic requirements were
recorded.
Results: Visual analog scale scores were signiﬁcantly lower in group C than in group S. The inci-
dence of moderate and severe headache was signiﬁcantly higher in group S (11 patients) when com-
pared with group C (2 patients). Analgesic demand was signiﬁcantly lower in group C than in group
S.
Conclusion: It seems that the incidence of postdural puncture headache decreases in those patients
who received caffeine sodium benzoate. The article can potentially help clinicians to use caffeine as
an effective drug for prevention of PDPH.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
Open access under CC BY-NC-ND license.1. Introduction
The incidence of postdural puncture headache (PDPH) is
estimated to be between 0% and 5% following spinal anesthe-
sia and up to 81% following accidental dural puncture during
epidural catheter insertion speciﬁcally in the pregnant woman
[1].
The incidence is partly dependent on the skill and experi-
ence of the person performing the lumbar puncture, but even
in the best hands headache occurs despite apparently a trau-
matic punctures of the theca [2].
PDPH is described as severe, distributed over the frontal
and occipital areas radiating to neck and shoulders. Neck stiff-
ness may be present. Pain is exacerbated by head movement,
and in upright posture, and relieved by lying down. An in-
crease in severity of headache on standing is the hallmark of
PDPH, in some patients PDPH can be debilitating and may in-
crease the length of hospital stay [3].
The presence of certain predisposing risk factors increases
the incidence of PDPH. The age group at highest risk is from
18 to 40 years, being 3–4 times that at the age of 65 years [4–6].
Also patient position during the procedure is one of the con-
tributing factors [7,8]. There is no evidence that either bed rest
or additional IV ﬂuids reduce the likelihood of a headache
developing following dural puncture.
Although Epidural Blood Patch (EBP) is one of the most
effective treatment methods for PDPH [8,9], pharmacologic
management is less invasive method in comparison with
EBP. Epidural injection of NaCL 0.9% or dextran is used as
an alternative when the EBP is unsuccessful or contraindicated
so pharmacological management to prevent PDPH is an
attractive option used to relief patient symptoms and to de-
crease the length of hospital stay [8].
Caffeine was ﬁrst reported as a treatment for PDPH in
1949. Caffeine is a central nervous system stimulant and is
thought to treat PDPH by inducing cerebral vasoconstriction.
Doses from 75 to 500 mg have been investigated and caffeine
has been administered orally, intramuscularly and intrave-
nously [11].
Well-designed, adequately powered, randomized controlled
trials showing the efﬁcacy of caffeine in PDPH are lacking.
Available studies are small and have methodological
shortcomings.
This double blinded randomized controlled study was de-
signed to evaluate the efﬁcacy and safety of caffeine for pre-
vention of PDPH in young adult patients received spinal
anesthesia.2. Patient and method
After approval of the ethical committee in New Jeddah Clinic
hospital (Saudi Arabia), a written informed consent was ob-
tained from 100 patients ASA physical status I–II, aged 20–
30 years, who were scheduled for elective knee surgeries either
arthroscopy or anterior cruciate ligament reconstruction (ACL
reconstruction), were enrolled in this study.
Patients were excluded from the study if they had allergy to
caffeine, a current psychiatric or neurological disorder or pre-
existing hypertension, or intolerance to caffeine, or had con-
sumed caffeinated beverages within the previous 4 h.
The patients received instructions on how to use a visual
analog scale for the assessment of the degree of headache that
consist of an unmarked 10 cm line, with 0 representing no
headache and 10 cm representing the worst headache imagin-
able [12].
In pre-anesthesia room, standard noninvasive blood pres-
sure (BP) and pulse rate were recorded and a peripheral 18-
gauge i.v. cannula was inserted. All patients received 20 mL/
kg of lactated Ringer’s solution as a prehydration measure
over 30 min. In the operative theater baseline values of heart
rate (HR), mean arterial pressure (MAP), and hemoglobin
oxygen saturation (SpO2) were recorded by Datex-Ohmeda;
Aisys (GE healthcare) before anesthesia and every ﬁve min.
during the procedure. For all cases in the study, the spinal
anesthesia was performed with the patient in the sitting posi-
tion at L3-4 or L4-5. Hyperbaric bupivacaine 0.5% 2–3 mL
was administered after conﬁrmation of cerebrospinal ﬂuid
through a 25-gauge Quincke spinal needle. Patients were
placed immediately in supine position. After ﬁxation of the
upper sensory level which assessed at 5-min intervals, a tourni-
quet was applied to the thigh to give bloodless ﬁeld. All oper-
ations were done by the same surgeon.
Patients were randomly allocated into two groups using a
computer generated randomization chart to receive intrave-
nously either caffeine sodium benzoate (CSB) 0.5 g, as a caf-
feine group (group C, n= 50) or normal saline as a
controlled group (group S, n= 50). The study drug (caffeine)
was diluted to a volume of 10 mL in one syringe and the other
syringe contains 10 ml normal saline both of them presented as
coded syringes by an anesthesiologist who was not involved in
the management of the patients. For the two groups the injec-
tion was given slowly intravenously within the ﬁrst 60 min
after lumber puncture and then 12-hourly for 48 h.
The hemodynamic parameters and any side effects such as
nausea, vomiting, rigor, discomfort or inadequate analgesia
Table 2 Postoperative mean arterial pressure (MAP) and
heart rate (HR) in the two groups of the study.
Group S N= 50 Group C N= 50
MAP
Baseline 96.1 ± 4.15 84.5 ± 3.6 <0.05
After 8 93.1 ± 3.2 83.8 ± 3.7 <0.05
After 16 88.4 ± 6.4 81.8 ± 5.2 <0.05
After 24 97.5 ± 5.5 87.1 ± 2.3 <0.05
After 32 95.6 ± 2.5 85.9 ± 2.4 <0.05
After 40 90.5 ± 2.8 88.3 ± 2.8 <0.05
After 48 92.12 ± 3.5 86.3 ± 2.6 <0.05
HR
Baseline 85.3 ± 3.7 69.1 ± 4.3 <0.05
After 8 84.8 ± 3.8 68.8 ± 5.4 <0.05
After 16 90.7 ± 4.5 82.8 ± 5.1 <0.05
After 24 92.7 ± 4.5 82.7 ± 4.5 <0.05
After 32 95.7 ± 4.5 80.7 ± 4.5 <0.05
After 40 89.7 ± 4.4 80.7 ± 4.5 <0.05
After 48 93.7 ± 4.5 84.7 ± 4.5 <0.05
Data are expressed as mean ± SD.
Figure 1 Comparison between the two studied groups as regards
VAS.
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hypotension or bradycardia happened, it must be treated by
i.v. administration of ephedrine in 5 mg increments and atro-
pine 0.3 mg respectively. At the end of procedure, patients
were shifted to recovery room with monitoring of hemody-
namics and sensory level.
Postoperatively, blood pressure and heart rate were re-
corded every 8 h in the following 48 h by a clinician blinded
to the study.
Severity of headache was scored and assessed by 10-point
(VAS) with 0 = no headache and 10 = worst headache imag-
inable [12], and according to the degree of pain given by the
patient, classiﬁcation of headache severity was done as follows:
no headache = 0, mild headache 63, moderate headache 4–6
and severe headache P7.
VAS was recorded every 6 h in the next 48 h by the same
clinician blinded to the study and for the next 3 days after hos-
pital discharge by telephone interview to complete 5 days after
the procedure.
When headaches failed to resolve within 1 h by bed rest and
ﬂuids, it was managed by incremental doses of intramuscular
morphine at a dose of 5 mg (rescue analgesia), and the total
amount of analgesic requirements was calculated.
3. Statistical analysis
MedCalc version 12.0.3 was used for the calculation of the
sample size, in a previous study, about 70% of patients demon-
strated satisfactory relief of PDPH within 60 min of used
500 mg intravenous caffeine sodium benzoate, so a sample size
of 100 (50 patients per group) provided 80% power at 0.05 le-
vel of signiﬁcance to detect a 40% difference in the proportion
of patients who attain satisfactory relief of headache between
single dose IV caffeine and placebo.
Statistical analysis was done on a personal computer using
the Statistical Package of Social Sciences (SPSSª, SPSS Inc.,
Chicago, IL) version 17.0.
Shapiro–Wilk test was ﬁrst conducted to test the hypothesis
that numerical data are normally distributed.
Normally distributed numerical data were presented as
mean (standard deviation) comparison between the two
groups was performed using unpaired Student’s t test. Cate-
gorical variable was compared using Chi-squared or Fisher’s
exact tests as appropriate. A P value less than 0.05 was consid-
ered statistically signiﬁcant
4. Results
One hundred patients were studied and divided into two
groups; 50 received caffeine and 50 received saline (placebo),Table 1 Demographic and operative data.
Group S N= 50
Age (years) 23.55 ± 3.29
Height (cm) 172.4 ± 2.46
Weight (kg) 72.6 ± 4.46
Sex prevalence (F/M) 23/27
Duration of surgery (min) 60 ± 4
Data are expressed as mean ± SD.and there was no statistically signiﬁcant difference between
the two groups as regards age, height, weight, sex and duration
of surgery (Table 1).
Intraoperatively, there were no signiﬁcant changes in MAP
and HR between the studied groups.
Postoperatively, MAP and HR were signiﬁcantly lower in
group C compared to group S during the whole postoperative
recording period (Table 2) (P< 0.05).
There was a statistical signiﬁcant difference between the
two groups of the study as regards the VAS scoresGroup C N= 50 P-value
22.91 ± 6.02 >0.05
174.1 ± 1.10 >0.05
71.8 ± 1.99 >0.05
24/26
65 ± 1 >0.05
Table 3 Postopertative analgesic consumption in ﬁrst 48 h.
Variable Group S N= 50 Group C N= 50 P-value
Cumulative postoperative morphine consumption in ﬁrst 48 h (mg) 20 (10–15) 5 (5–7)* <0.001
Time to ﬁrst analgesic (h) 1 (1–2) 6 (5–8)* <0.001
Data are given as means ± SD.
*
P value Signiﬁcant
Table 4 Total number of headaches of given severity recorded by 100 patients given caffeine or placebo.
Group S N= 50 Group C N= 50 P-value
NO headache 31 46 <0.001
Mild headache 8 2 <0.001
Moderate headache 4 2 <0.05
Severe headache 7 0 <0.001
Data are expressed as mean ± SD.
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C (Fig. 1). There was a high statistical signiﬁcant difference be-
tween the two groups as regards total morphine consumption
(P< 0.001) (Table 3). There was also, a high signiﬁcant differ-
ence between the groups as regards the time of ﬁrst rescue
analgesic dose (P< 0.001) (Table 3), group S patients needed
the ﬁrst analgesic dose within 1 h postoperatively while group
C patients needed the ﬁrst analgesic dose after 12 h. As shown
in (Fig. 1) VAS at rest was signiﬁcantly high in group S from
the 1st hour postoperatively in comparison to groups C
(P< 0.001) and that was managed as scheduled in the study
protocol by giving 5 mg morphine intra-muscularly (IM) with
subsequent decrease in VAS scores. Six hours postoperatively,
the VAS scores started to increase again and became signiﬁ-
cantly higher in S group (P< 0.001), so a second dose of res-
cue analgesia (in the form of 5 mg morphine intramuscularly)
was given with subsequent decrease in VAS scores. Nine pa-
tients needed a 3rd dose of rescue analgesia between the 12th
and 48th hour postoperatively.
In group C, the VAS started to increase after the 12th hour
postoperatively before which the VAS remained <50 mm.
Only 2 patients needed a rescue analgesic dose of morphine be-
tween the 12th and 48th hour postoperatively.
In group C, 4 patients (8%) developed headache (2 (4%) of
them had mild headache and the other 2(4%) had moderate
headache) in 48 h after operation. In control group (group
S), 19 (38%) patients were reported with the headache (8
(16%) of them had mild headache, 4 (8%) of them had mod-
erate headache and the remaining 7 (14%) complained of se-
vere headache) which is statistically signiﬁcant (P< 0.001).
Table 4 shows the headache incidence in the two studied
groups.
No signiﬁcant side effects of the studied drugs occurred
during the ﬁrst 48 h postoperatively only two patients in group
C complained from mild and transient ﬂushing and it was re-
solved spontaneously without treatment.
5. Discussion
PDPH is described as severe, searing and spreading like hot
metal, distributed over the frontal and occipital areas radiatingto neck and shoulders. Ninety percent of headaches occur
within the ﬁrst 3 days of the procedure, and 66% start within
the ﬁrst 48 h. rarely, the headache develops between 5 and
14 days after the procedure. Headache may present immedi-
ately after dural puncture [13].
The current clinical study was designed to evaluate the efﬁ-
cacy and safety of prophylactic administration of intravenous
caffeine for prevention of PDPH in young adult patients (the
most risky age group to develop headache) received spinal
anesthesia.
The main ﬁnding in this study was that the reduction in the
incidence of occurrence of PDPH is more in caffeine group
than in the control group. VAS is higher in control group than
in caffeine group. Also the doses of analgesics in control group
were greater than the doses given in caffeine group.
The pathogenesis of PDPH remains unclear but is thought
to be caused by CSF leakage into the epidural space via a tear
in the dura. CSF loss leads to a reduction in intracranial pres-
sure and downward traction on pain-sensitive intracranial
structures, including veins, meninges and cranial nerves, result-
ing in a headache that is classically worse in the upright posi-
tion. The fall in intracranial pressure may also cause
compensatory cerebro-vascular vasodilation and this may con-
tribute to the development of the headache [3].
Prevention and treatment for headache following dural
puncture allow early ambulation, enabling effective physio-
therapy and early discharge from the hospital.
The most clinically evaluated treatment option for PDPH is
use of an epidural blood patch (EBP). However, this invasive
procedure carries a risk of infection, seizures, back pain, and
exacerbation of the headache [14,15].
Other agents that have been evaluated for the treatment of
PDPH include epidural administration of saline, caffeine,
theophylline, sumatriptan, adrenocorticotropic hormone,
dextran patch, morphine sulfate, and bed rest. Caffeine ther-
apy is a noninvasive, safe alternative treatment for PDPH;
however, caffeine has been poorly studied for this indication
[15].
The proposed mechanism of action of caffeine involves a
decrease in cerebral blood ﬂow, a reduction in cerebrospinal
pressure, and cerebral vasoconstriction [16,17].
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logic prophylaxes for prevention of PDPH but all the previous
studies were used it or other drugs as a treatment after head-
ache occurred.
Methylxanthine derivatives, such as caffeine and aminoph-
ylline, are a mainstay of treatment for PDPH although their
efﬁcacy is not proven [18]. Under the theory, methylxanthine
derivatives relieve the headache by blocking adenosine recep-
tors, which in turn leads to vasoconstriction of cerebral blood
vessels [19]. Methylxanthines may also stimulate sodium–
potassium pumps to increase CSF production, which can lead
to headache relief [19].
Well-designed, adequately powered, randomized controlled
trials showing the efﬁcacy of caffeine in PDPH are lacking.
Available studies are small and have methodological short-
comings. For example, in the study by Sechzer et al. [20], 41
patients were given 500 mg of caffeine sodium benzoate or sal-
ine intravenously [20]. The headache was relieved in 75% of
patients after the ﬁrst dose of caffeine compared with 14%
in the saline group. Further improvement was seen with a sec-
ond dose, which was given 24 h after the ﬁrst dose. In this
study, relief from caffeine may have been temporary.
Twenty-four hours after treatment, there were no signiﬁcant
differences between the caffeine treated and saline treated
groups [20]. Treatment with intravenous caffeine was not asso-
ciated with a reduction in the number of patients who required
epidural blood patches (EBP). The results of this study were
different from the current study, because Sechzer et al., used
only two doses of caffeine instead of four doses in our study
and also they gave caffeine after headache occurred. This
explanation was supported by Sechzer conclusion which was
an intravenous injection of 0.5 g CSB is effective for treatment
of spinal headache also supplemental doses may be adminis-
tered at 8 h intervals.
In a widely quoted, but uncontrolled nonrandomized study,
Jarvis et al. [21] reported that PDPH was relieved in 80% of
patients treated with intravenous CSB (500 mg) in 1 L of Ring-
er’s lactate solution, followed by an additional liter of Ringer’s
lactate during the subsequent 2 h. Although the results of the
study by Jarvis et al. [21] were promising and consistent with
those reported by Sechzer [20], this nonrandomized study is
confounded by the unknown effects of acute 2-L hydration
on PDPH, inasmuch as no placebo control was used.
The dose of caffeine used in our study (500 mg) contains
250 mg of caffeine plus 250 mg of sodium benzoate to enhance
solubility before parenteral use, but in the study by Sechzer
[20] oral caffeine (300 mg of anhydrous powder) the dose
was 120% greater than the dose used in our study, caffeine
is almost completely absorbed after oral administration (with
minimal ﬁrst-pass effect) [22].
In another study William and his colleagues [23], demon-
strated that a single oral dose of caffeine (300 mg) is safe
and efﬁcacious, and merits consideration in the early treatment
for PDPH. In contrast to intravenous caffeine, the use of oral
caffeine is more convenient and less expensive.
Although a majority of patients had relief of headaches
without recurrence, some did recur after completion of treat-
ment. The tendency for caffeine, as a single oral dose, to pro-
vide only temporary relief from PDPH precludes its
recommendation as a deﬁnitive treatment for this syndrome.
Whether long-term relief would occur with multiple doses of
caffeine in combination with ﬂuids, analgesics, or othervasoactive drugs remains to be determined. Their study done
on forty postpartum patients with postdural puncture head-
ache (PDPH) were randomly assigned to receive oral caffeine
(300 mg) or a placebo. Intensity of headache, quantitated using
a visual analogue pain scale (VAS), was assessed immediately
before drug administration and 4 and 24 h later. Relief of
PDPH measured as AVAS (initial VAS–VAS at 4 h) was sig-
niﬁcantly better in the caffeine than in the placebo group
(P= 0.014). Six patients (30%) whose PDPH was relieved
by caffeine at 4 h had recurrence of symptoms the following
day.
The present ﬁndings are in agreement with those from stud-
ies using intravenous and oral caffeine but in the current study
using of caffeine as a prophylactic measure and also every 12 h
for the ﬁrst 2 days postoperatively that gave better control of
PDPH and better results.
In our study side effects were infrequent and mild and re-
lived without treatment, and it was in the form of mild and
transient ﬂushing in two patients only in caffeine group.
In conclusion, this study demonstrates that use of caffeine
(500 mg) IV is safe and efﬁcacious, and merits consideration
in the early prevention of PDPH.
Conﬂict of interest
None declared.
References
[1] Costigan SN, Sprigge JS. Dural puncture: the patients’
perspective. A patient survey of cases at a DGH maternity
unit 1983–1993. Acta Anaesthesiol Scand 1996;40:710–4.
[2] Hasan A, Pearce J, Miller E. Vasopressin in prevention of
lumber puncture headache. Br Med J 1968;4:677–8.
[3] Alam MR, Raheen MR, Iqbal KM, Chowdhury MRA.
Headache following spinal anaesthesia: a review on recent
update. J Bangladesh Coll Phys Surg 2011;29(1).
[4] Velde MV, Schepers R, Berends N. Ten years of experience with
dural punctures and PDPH in obstetric anaesthesia department.
Int J Obstet Anaesth 2009;17:329–35.
[5] Zencira Beyazit. PDPH & pregabailin. J Pain Res 2010;3:11–4.
[6] Candido Kenneth D, Stevens Rom A. Post dural puncture
headache: pathophysiology, prevention and treatment. Best
Pract Res Clin Anaesth 2003;17:451–69.
[7] Jones RJ. The role of recumbency in the prevention and
treatment of postspinal headache. Anesth Analg
1974;53:788–95.
[8] Flaatten H, Krakenes J, Vedeler C. Post-dural puncture related
complications after diagnostic lumbar puncture, myelography
and spinal anesthesia. Acta Neurol Scand 1998;98:445–51.
[9] Frank Robert L. Lumbar puncture and postdural puncture
headaches: implications for the emergency physicians. J Emerg
Med 2008;35:149–52.
[10] Schwarz U, Schwan C, Strumpf M, et al. Post dural puncture
headache: diagnosis, prevention and therapy. Schmerz
1996;13:332–40.
[11] Halker RB et al. Caffeine for the prevention and treatment of
postdural puncture headache: debunking the myth. Neurologist
2007;13:323–7.
[12] Revill SI, Robinson JO, Rosen M, Hogg MIJ. The reliability of
a linear analogue for evaluating pain. Anaesthesia
1976;31:1191–8.
[13] Weir EC. The sharp end of the dural puncture. Br Med J
2000;320:127–8.
186 A. Ragab, K.N. Facharzt[14] Sudlow C, Warlow C. Epidural blood patching for preventing
and treating post-dural puncture headache. Cochrane Database
Syst Rev 2001;(2).
[15] Abouleish E, Vega S, Blendinger I, Tio TO. Long term follow-
up of epidural blood patch. Anesth Analg 1975;54:459–63.
[16] Morewood GH. A rational approach to the cause, prevention
and treatment of postdural puncture headache. Can Med Assoc
J 1993;149:1087–93.
[17] Choi A, Laurito CE, Cunningham FE. Pharmacologic
management of postdural headache. Ann Pharmac Other
1996;30:831–9.
[18] Lin W, Geiderman J. Medical myth: ﬂuids, bed rest, and caffeine
are effective in preventing and treating patients with post-
lumbar puncture headache. West J Med 2002;176:69–70.
[19] Straube A, Neudert C, Glas M, Bru¨ning R, Padovan CS. The
so-called spontaneous low CSF pressure pressure syndrome.Case results indicating a disturbance in CSF/blood volume
regulation. Nervenarzt 2004;75:1194–9.
[20] Sechzer PH, Abe L. Post-spinal anesthesia headache and
treatment with caffeine: evaluation with demand method. Part
I. Curr Ther Res 1976;24:307–12.
[21] Jarvis AP, Greenawalt JW, Fagraeus L. Intravenous caffeine for
post-dural puncture headache. Anesth Analg 1986;65:316.
[22] Bonati M, Latini R, Galleti F, Young JF, Tognoni G, Garattini
S. Caffeine disposition after oral doses. Clin Pharmacol Ther
1982;32:98–106.
[23] Camann William R, Scott Murray R, Mushlin Phillip S,
Lambert Donald H. Effects of oral caffeine on postdural
puncture headache a double-blind, placebo-controlled trial.
Anesth Analg 1990;70:181–4.
